Ligand ID: BQ1 Drugbank ID: DB08903(Bedaquiline) Indication:Bedaquiline is indicated as part of combination therapy in adults (≥ 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB). |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.07A | 15.67 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 0.94A | 14.29 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 1ysy | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 3 / 3 | GLU A 52ALA A 50PHE A 51 | 1.03A | 19.15 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 267PHE A 223 | 1.00A | 15.28 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2a5k | 3C-LIKE PEPTIDASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 0.97A | 14.29 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 8 | ALA F 155ALA F 107ILE F 111ALA B 53LEU B 61 | 1.40A | 17.73 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2d2d | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 0.93A | 14.29 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | GLU A 71ALA A 69PHE A 70 | 1.05A | 16.86 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2gri | NSP3 (SARSr) | 3 / 3 | GLU A 53ALA A 55PHE A 54 | 0.59A | 15.38 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2idy | NSP3 (SARSr-CoV) | 3 / 3 | GLU A 53ALA A 55PHE A 54 | 0.77A | 15.38 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2kqv | NSP3 (SARSr-CoV) | 3 / 3 | GLU A 97ALA A 98PHE A 93 | 1.05A | 17.95 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2liz | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.97A | 21.14 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2ofz | NUCLEOCAPSID PROTEIN (SARS-COVTor2) | 5 / 8 | ALA A 139ALA A 135ILE A -3ALA A 126TYR A 124 | 1.73A | 20.77 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2op9 | REPLICASEPOLYPROTEIN 1AB(PP1AB, ORF1AB)3C-LIKE PROTEINASE(3CL-PRO, 3CLP) (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.06A | 15.67 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 8 | ALA D 108ALA D 115ILE D 107ALA D 137LEU D 119 | 1.58A | 13.87 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 0.97A | 12.62 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2qc2 | 3C-LIKE PROTEINASE (-) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 1.05A | 14.29 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2qcy | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.05A | 14.29 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2qiq | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.01A | 15.67 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 8 | ALA B 234ALA B 231ILE B 235GLU B 339LEU B 331 | 1.64A | 13.83 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 1.00A | 15.67 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | GLU A 23ALA A 226PHE A 230 | 0.96A | 16.94 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | GLU A 23ALA A 226PHE A 230 | 0.92A | 16.94 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.95A | 15.67 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3e9s | NSP3 (SARSr-CoV) | 3 / 3 | GLU A 71ALA A 69PHE A 70 | 1.03A | 12.97 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 0.83A | 14.95 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 8 | ALA A 286ALA A 284GLU A 288ALA A 291LEU A 208 | 1.41A | 14.95 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3ebn | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 1.04A | 21.14 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 267PHE B 223 | 1.03A | 16.04 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.95A | 15.67 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 0.96A | 14.29 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.97A | 14.29 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 3 / 3 | GLU B 71ALA B 69PHE B 70 | 0.87A | 12.97 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | GLU A 23ALA A 226PHE A 230 | 1.04A | 14.42 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.92A | 15.67 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 1.01A | 13.59 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 3 / 3 | GLU A 71ALA A 69PHE A 70 | 1.02A | 16.86 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 4mds | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.97A | 15.67 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 0.91A | 14.29 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5f22 | NSP8NSP7 (SARSr-CoV) | 5 / 8 | ALA B 155ALA B 107ILE B 111ALA A 53LEU A 61 | 1.46A | 18.66 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 210ALA A 211ALA A 260LEU A 268 | 1.60A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 210ALA A 255TYR A 209LEU A 250 | 1.47A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 211ALA A 255TYR A 209LEU A 250 | 1.72A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 260ILE A 259PHE A 219LEU A 220 | 1.46A | 16.88 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.33A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 213ALA A 260LEU A 253 | 1.51A | 16.88 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.31A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 281ALA A 266LEU A 271 | 1.32A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 260ALA A 211TYR A 209LEU A 205 | 1.35A | 16.88 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 3 / 3 | GLU D 71ALA D 69PHE D 70 | 0.98A | 12.85 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 8 | ALA B 866ALA B 875ILE A 687ALA B 857TYR B 771 | 1.48A | 5.85 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 3 / 3 | GLU B 131ALA B 156PHE B 157 | 0.91A | 5.85 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5x5c | S PROTEIN (MERS-CoV) | 4 / 8 | ALA C 968ALA C 969ILE C 970PHE C 972 | 1.01A | 4.98 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 8 | ALA C 971ILE C 962GLU C 730ALA C 732LEU C 959 | 1.79A | 5.87 | ALA C 971 ( 0.0A)ILE C 962 ( 0.7A)GLU C 730 ( 0.5A)ALA C 732 ( 0.0A)LEU C 959 ( 0.6A) | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ALA B 251ALA B 250GLU B 93LEU B 235 | 1.00A | 5.87 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | GLU B 131ALA B 156PHE B 157 | 0.86A | 5.68 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 8 | ALA B 971ILE B 962GLU B 730ALA B 732LEU B 978 | 1.32A | 5.60 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | GLU A 131ALA A 156PHE A 157 | 0.68A | 5.60 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6iex | MHC CLASS I ANTIGEN (Homosapiens;SARSr-CoV) | 5 / 8 | ALA A 135ALA A 136ILE A 124TYR A 123LEU C 10 | 1.65A | 17.11 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6jyt | HELICASE (SARSr-CoV) | 5 / 8 | ALA B 123ILE B 121ALA B 407PHE B 422LEU B 417 | 1.78A | 11.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6lzg | ACE2 (Homosapiens) | 5 / 8 | ALA A 372ALA A 311ILE A 307ALA A 413LEU A 423 | 1.78A | 8.53 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m18 | ACE2 (Homosapiens) | 4 / 8 | ALA B 342ILE B 54ALA B 46TYR B 50 | 0.96A | 6.96 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m18 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 8 | ALA A 498ALA A 282ALA A 91PHE A 90LEU A 286 | 1.72A | 10.30 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 1.16A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | GLU B 270ALA B 266PHE B 223 | 1.14A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | ALA C 260ALA C 211TYR C 209LEU C 205 | 1.31A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | ALA D 211ILE D 281ALA D 266LEU D 271 | 1.22A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.27A | 15.13 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.28A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 281ALA A 266LEU A 271 | 1.31A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 8 | ALA A 512ALA A 502ILE A 562ALA B 86LEU A 372 | 1.44A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA B 152ALA B 150ALA A 399LEU A 389 | 1.23A | 18.18 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 126LEU B 128 | 1.14A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 449ALA A 448ILE A 450ALA B 162 | 1.23A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 716ILE A 715ALA A 771LEU A 707 | 1.23A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 188LEU A 389 | 1.25A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 863ILE A 888ALA A 423PHE A 422 | 1.29A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 502ILE A 562ALA B 86LEU A 372 | 1.25A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6m71 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 376ILE A 539ALA A 383LEU A 673 | 1.23A | 6.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 8 | ALA A 971ILE A 962GLU A 730ALA A 732LEU A 978 | 1.44A | 5.69 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6nur | NSP7NSP8 (SARSr-CoV) | 5 / 8 | ALA D 150ALA D 102ILE D 106ALA C 48LEU C 56 | 1.41A | 18.18 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6nus | NSP12NSP8 (SARSr-CoV) | 5 / 8 | ALA A 512ALA A 502ILE A 562ALA B 86LEU A 372 | 1.46A | 6.31 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 8 | ALA B1016ILE A1013GLU B 773ALA B 771LEU B1012 | 1.62A | 5.60 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 154ILE A 18ALA A 129LEU A 140 | 1.27A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 154ILE B 18ALA B 129LEU B 140 | 1.24A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 8 | ALA B1016ILE A1013GLU B 773ALA B 771LEU B1012 | 1.61A | 5.77 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 8 | ALA H 71ALA H 78ILE H 34LEU H 4 | 1.52A | 21.02 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | ALA L 144GLU L 161PHE H 166LEU L 135 | 1.47A | 17.83 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | ILE C 358GLU C 340ALA C 344PHE C 342 | 1.34A | 19.50 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | ALA L 34ALA L 51ILE L 48LEU L 73 | 1.60A | 17.83 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | ALA L 19ILE L 75TYR L 86LEU L 47 | 1.42A | 17.83 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | ALA C 435ILE C 434ALA C 411PHE C 429 | 1.56A | 19.50 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 8 | ALA H 71ILE H 69ALA H 93LEU H 80 | 1.72A | 21.02 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | ALA C 352ILE C 468TYR C 351LEU C 492 | 1.54A | 19.50 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | ALA C 397ALA C 435PHE C 374LEU C 368 | 1.43A | 19.50 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | GLU L 187ALA L 184TYR L 186LEU L 181 | 1.56A | 17.83 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | ALA H 137ALA L 112PHE L 139LEU L 136 | 1.48A | 21.02 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 4 / 8 | ALA C 435ILE C 434ALA C 372LEU C 368 | 1.34A | 19.50 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 8 | ALA L 84TYR L 87PHE L 98LEU H 45 | 1.46A | 17.83 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6990ALA A6808TYR A6851LEU A6852 | 1.39A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6990ALA A6808TYR A6851LEU A6855 | 1.36A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A7002ILE A6969TYR A6979LEU A6978 | 1.38A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A6969TYR A6979LEU A6978 | 1.56A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ILE A6926ALA A6990PHE A6991LEU A6852 | 1.41A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A7005ALA A6858LEU A6855 | 1.07A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 8 | ILE A6838GLU B4319ALA B4314LEU B4298 | 1.33A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6919ILE A7088ALA A6914LEU A6909 | 1.39A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A7005TYR A6851LEU A6852 | 1.16A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ILE A6926ALA A6843TYR A6845LEU A6848 | 1.44A | 20.73 | NoneNoneSAM A7104 (-4.6A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A6926ALA A6858LEU A6887 | 1.58A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A7002ALA A6990ALA A7024PHE A7028 | 1.48A | 20.73 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | GLU A7001ALA A7002PHE A6991LEU A6848 | 1.56A | 20.73 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.09A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.07A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 124ILE A 23ALA A 39LEU A 53 | 1.65A | 19.88 | NoneAMP A 201 ( 4.0A)NoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 39ALA A 38ALA A 89LEU A 122 | 1.54A | 19.88 | NoneAMP A 201 ( 3.9A)NoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 154ALA A 124ILE A 23LEU A 88 | 1.44A | 19.88 | AMP A 201 ( 4.5A)NoneAMP A 201 ( 4.0A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 39ALA B 38ALA B 89LEU B 93 | 1.52A | 19.88 | NoneMES B 201 ( 3.4A)NoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 154ALA B 124ILE B 23LEU B 88 | 1.42A | 19.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 70ILE A 69ALA A 60LEU A 43 | 1.31A | 19.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 27ALA B 89ALA B 38LEU B 122 | 1.71A | 19.88 | NoneNoneMES B 201 ( 3.4A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 21ALA B 154ALA B 38LEU B 126 | 1.67A | 19.88 | NoneNoneMES B 201 ( 3.4A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 154ALA A 124ALA A 129LEU A 140 | 1.71A | 19.88 | AMP A 201 ( 4.5A)NoneAMP A 201 ( 3.4A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 124ILE B 23ALA B 39LEU B 53 | 1.67A | 19.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 39ALA A 38ALA A 89LEU A 93 | 1.54A | 19.88 | NoneAMP A 201 ( 3.9A)NoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 154ILE B 18ALA B 129LEU B 140 | 1.39A | 19.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 134ALA A 129ALA A 124LEU A 140 | 1.55A | 19.88 | NoneAMP A 201 ( 3.4A)NoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 134ALA B 129ALA B 124LEU B 140 | 1.57A | 19.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA B 70ILE B 69ALA B 60LEU B 43 | 1.30A | 19.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 154ILE A 18ALA A 129LEU A 140 | 1.32A | 19.88 | AMP A 201 ( 4.5A)NoneAMP A 201 ( 3.4A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 21ALA A 154ALA A 38LEU A 126 | 1.59A | 19.88 | NoneAMP A 201 ( 4.5A)AMP A 201 ( 3.9A)AMP A 201 ( 4.4A) | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 39ALA A 38ALA A 27LEU A 122 | 1.44A | 19.88 | NoneAMP A 201 ( 3.9A)NoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C7002ILE C6969TYR C6979LEU C6978 | 1.37A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLU C7001ALA C7002PHE C6991LEU C6848 | 1.56A | 22.38 | FMT C7108 ( 3.9A)NoneNoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A6969TYR A6979LEU A6978 | 1.57A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ILE C6926ALA C6843TYR C6845LEU C6848 | 1.45A | 22.38 | NoneNoneSAM C7105 ( 4.5A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6990ALA A6808TYR A6851LEU A6855 | 1.37A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A6925ALA A6858LEU A6959 | 1.60A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 8 | ILE A6838GLU B4319ALA B4314LEU B4298 | 1.36A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A6926ALA A6858LEU A6887 | 1.58A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C7002ALA C6990ALA C7024PHE C7028 | 1.48A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ILE B4334ALA B4324TYR B4329LEU B4328 | 1.62A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ALA D4271ALA B4279TYR B4283LEU B4284 | 1.15A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6808ALA C6966TYR C6851LEU C6855 | 1.60A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ALA B4271ALA D4279TYR D4283LEU D4284 | 1.06A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A7002ILE A6969TYR A6979LEU A6978 | 1.40A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ALA D4273ALA D4271TYR B4283LEU B4284 | 1.73A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A7005TYR A6851LEU A6852 | 1.17A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6990ALA C6808TYR C6851LEU C6855 | 1.38A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6990ALA C6808TYR C6851LEU C6852 | 1.39A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6966ILE C7005ALA C6858LEU C6855 | 1.07A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 8 | ILE C6838GLU D4319ALA D4314LEU D4298 | 1.37A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ALA B4273ALA B4271TYR D4283LEU D4284 | 1.57A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6990ALA A6808TYR A6851LEU A6852 | 1.36A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6966ILE C6926ALA C6858LEU C6887 | 1.58A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A7005ALA A6858LEU A6855 | 1.07A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | GLU A7001ALA A7002PHE A6991LEU A6848 | 1.56A | 22.38 | FMT A7104 ( 4.0A)NoneNoneNone | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ALA B4273ALA B4271ALA D4285TYR D4283 | 1.72A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6990ILE C6969TYR C6979LEU C6978 | 1.56A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP10 (SARS-CoV-2) | 4 / 8 | ILE B4291ALA B4279TYR B4280LEU B4365 | 1.67A | 19.72 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ILE A6926ALA A6843TYR A6845LEU A6848 | 1.44A | 22.38 | NoneNoneSAM A7102 ( 4.5A)None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6990ILE C7005TYR C6851LEU C6852 | 1.19A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A7002ALA A6990ALA A7024PHE A7028 | 1.50A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6808ALA A6966TYR A6851LEU A6855 | 1.61A | 22.38 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU C 143ALA C 144PHE C 147LEU C 150 | 1.00A | None | |||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 70ALA A 68PHE A 69 | 1.16A | 13.22 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 70ALA A 68PHE A 69 | 1.16A | 13.22 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | ALA B 139ALA B 144ALA B 153LEU B 87 | 1.31A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | GLU A 143ALA A 144PHE A 147LEU A 150 | 0.90A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 4 / 8 | ALA A 139ALA A 144ALA A 153LEU A 87 | 1.31A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 8 | ALA A 70ILE A 69ALA A 60LEU A 43 | 1.30A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 8 | ALA B 150ALA B 102ILE B 106ALA A 48LEU A 56 | 1.45A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | ILE B 320ALA A 305PHE A 307LEU A 353 | 1.27A | None CL A 401 ( 4.3A)NoneNone | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | ILE E 320ALA F 305PHE F 307LEU F 353 | 1.30A | None CL F 401 ( 4.0A)NoneNone | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 4 / 8 | ILE D 320ALA C 305PHE C 307LEU C 353 | 1.23A | None CL C 401 ( 4.2A)NoneNone | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wjt | NSP10 (SARS-CoV-2) | 4 / 8 | ALA D4271ALA B4279TYR B4283LEU B4284 | 1.11A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA C6966ILE C7005ALA C6858LEU C6855 | 1.07A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA C6990ILE C7005TYR C6851LEU C6852 | 1.18A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A7005TYR A6851LEU A6852 | 1.15A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wjt | NSP10 (SARS-CoV-2) | 4 / 8 | ALA B4271ALA D4279TYR D4283LEU D4284 | 1.05A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A7005ALA A6858LEU A6855 | 1.05A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wkq | NSP10 (SARS-CoV-2) | 4 / 8 | ALA D4271ALA B4279TYR B4283LEU B4284 | 1.13A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6990ILE C7005TYR C6851LEU C6852 | 1.19A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wkq | NSP10 (SARS-CoV-2) | 4 / 8 | ALA B4271ALA D4279TYR D4283LEU D4284 | 1.05A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | ALA C6966ILE C7005ALA C6858LEU C6855 | 1.05A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A7005ALA A6858LEU A6855 | 1.06A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A7005TYR A6851LEU A6852 | 1.16A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | ALA B 109ILE B 116ALA B 81LEU B 120 | 1.25A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | ALA A 109ILE A 116ALA A 81LEU A 120 | 1.17A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | ALA B 109ILE B 108ALA B 138LEU B 120 | 1.29A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | ALA A 109ILE A 108ALA A 81LEU A 120 | 1.30A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 8 | ALA B 109ILE B 108ALA B 81LEU B 120 | 1.28A | None | |||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.06A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.04A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 70ILE A 69ALA A 60LEU A 43 | 1.29A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA C 70ILE C 69ALA C 60LEU C 43 | 1.26A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA D 70ILE D 69ALA D 60LEU D 43 | 1.27A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6990ILE A7005TYR A6851LEU A6852 | 1.20A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 8 | ALA A6966ILE A7005ALA A6858LEU A6855 | 1.08A | NoneNoneNone8NK A7103 (-3.6A) | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 8 | ALA D 150ALA D 102ILE D 106ALA C 48LEU C 56 | 1.45A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 8 | ALA B 150ALA B 102ILE B 106ALA A 48LEU A 56 | 1.42A | EDO B 302 (-3.7A)EDO B 302 ( 4.2A)NoneNoneNone | |||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.19A | 15.13 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.20A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | GLU A 70ALA A 68PHE A 69 | 1.04A | 12.26 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 3 / 3 | GLU A 70ALA A 68PHE A 69 | 1.04A | 12.26 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 210ALA A 211ALA A 260LEU A 268 | 1.60A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 281ALA A 266LEU A 271 | 1.31A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 285ILE A 281PHE A 3LEU A 282 | 1.72A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 260ALA A 211TYR A 209LEU A 205 | 1.33A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 210ALA A 255TYR A 209LEU A 250 | 1.46A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 211ALA A 255TYR A 209LEU A 250 | 1.71A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 260ILE A 259PHE A 219LEU A 220 | 1.45A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 213ALA A 260LEU A 253 | 1.51A | 16.88 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.32A | 16.88 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.30A | 16.88 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 8 | ALA B 150ALA B 152GLU A 50PHE A 49 | 1.13A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 8 | ALA B 150ILE B 106GLU A 50ALA A 48LEU A 56 | 1.64A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 6 / 8 | ALA B 150ALA B 102ILE B 106GLU A 50ALA A 48LEU A 56 | 1.71A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 8 | ALA B 102ALA B 150GLU A 50LEU B 153 | 1.21A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 8 | ALA D 150ALA D 102ILE D 106ALA C 48LEU C 56 | 1.42A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | ALA E 435ILE E 434ALA E 372LEU E 368 | 1.24A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | ALA A 435ILE A 434ALA A 372LEU A 368 | 1.25A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | ALA E 435ILE E 434ALA E 372LEU E 368 | 1.19A | None | |||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.24A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.22A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | ALA A 435ILE A 434ALA A 372LEU A 368 | 1.24A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 8 | ALA E 435ILE E 434ALA E 372LEU E 368 | 1.24A | None | |||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.27A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.26A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | ALA A 154ILE A 18ALA A 129LEU A 140 | 1.30A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | ALA E 70ILE E 69ALA E 60LEU E 43 | 1.28A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | ALA A 70ILE A 69ALA A 60LEU A 43 | 1.27A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | ALA B 70ILE B 69ALA B 60LEU B 43 | 1.27A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | ALA C 70ILE C 69ALA C 60LEU C 43 | 1.27A | NoneNoneEDO D 204 ( 4.8A)None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 8 | ALA D 70ILE D 69ALA D 60LEU D 43 | 1.29A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 281ALA A 266LEU A 271 | 1.31A | None | |||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.19A | 15.13 | None | ||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.18A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 126LEU B 128 | 1.21A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 512ILE A 562ALA A 490LEU A 527 | 1.30A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 8 | ALA D 150ALA D 102ILE D 106ALA C 48LEU C 56 | 1.42A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 502ILE A 562ALA B 86LEU A 372 | 1.21A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 8 | ALA D 150ALA D 102ILE D 106GLU C 50ALA C 48 | 1.15A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 716ILE A 715ALA A 771LEU A 707 | 1.19A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 502ALA A 512ILE A 562ALA A 685 | 1.31A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 376ILE A 539ALA A 383LEU A 673 | 1.29A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP7NSP8 (SARS-CoV-2) | 4 / 8 | ALA D 150ILE D 120GLU C 50ALA C 48 | 1.18A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA B 152ALA B 150ALA A 399LEU A 389 | 1.17A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 449ALA A 448ILE A 450ALA B 162 | 1.31A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 8 | ALA A 512ALA A 502ILE A 562ALA B 86LEU A 372 | 1.43A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7btf | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 188LEU A 389 | 1.23A | None | |||
![]() | 4V1F_A_BQ1A1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.26A | 15.13 | None | ||
![]() | 4V1F_C_BQ1C1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 3 / 3 | GLU A 270ALA A 266PHE A 223 | 1.28A | 15.13 | None | ||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 4 / 8 | ALA A 211ILE A 281ALA A 266LEU A 271 | 1.31A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 716ILE A 715ALA A 771LEU A 707 | 1.19A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 376ILE A 539ALA A 383LEU A 673 | 1.24A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP8 (SARS-CoV-2) | 4 / 8 | ALA D 150ALA D 152ALA D 126LEU D 122 | 1.06A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 188LEU A 389 | 1.22A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 126LEU B 128 | 1.17A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 8 | ALA A 512ALA A 502ILE A 562ALA B 86LEU A 372 | 1.50A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 502ILE A 562ALA B 86LEU A 372 | 1.17A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA B 152ALA B 150ALA A 399LEU A 389 | 1.22A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 8 | ALA D 150ALA D 102ILE D 106ALA C 48LEU C 56 | 1.46A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 716ILE A 715ALA A 771LEU A 707 | 1.10A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 8 | ALA A 512ALA A 502ILE A 562ALA B 86LEU A 372 | 1.47A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | ALA A 376ILE A 539ALA A 383LEU A 673 | 1.28A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA B 152ALA B 150ALA A 399LEU A 389 | 1.19A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 8 | ILE A 201GLU A 84PHE A 219LEU A 90 | 1.29A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 126LEU B 128 | 1.19A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 502ILE A 562ALA B 86LEU A 372 | 1.31A | None | |||
![]() | 4V1F_B_BQ1B1087_0 (F0F1 ATP SYNTHASESUBUNIT C) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 4 / 8 | ALA A 399ALA A 400ALA B 188LEU A 389 | 1.23A | None |